Showing 6891-6900 of 8859 results for "".
- Provectus Announces Name Change to Provectus Biopharmaceuticalshttps://practicaldermatology.com/news/20131218-provectus_announces_name_change_to_provectus_biopharmaceuticals/2459391/
- Almirall S.A. to Aquire Aqua Pharmaceuticalshttps://practicaldermatology.com/news/20131217-almirall_sa_to_aquire_aqua_pharmaceuticals/2459392/
- Mela Sciences Reports Positive Feedback on MelaFind during Clinical Advisory Meetinghttps://practicaldermatology.com/news/20131210-mela_sciences_reports_positive_feedback_on_melafind_during_clinical_advisory_meeting/2459396/
- NIH Awards Icahn School of Medicine at Mount Sinai $2.7 Million for Eczema Researchhttps://practicaldermatology.com/news/20131126-nih_awards_icahn_school_of_medicine_at_mount_sinai_27_million_for_eczema_research/2459404/
- Merz Pharma Group Acquires Anteis S.A.https://practicaldermatology.com/news/20131112-merz_pharma_group_acquires_anteis_sa/2459418/
- Robert Ryan of Scioderm Appointed Member of DebRA Boardhttps://practicaldermatology.com/news/20131021-robert_ryan_of_scioderm_appointed_member_of_debra_board/2459434/Scioderm, Inc.'s co-founder and CEO Robert
- Novan Awarded Contract by BARDA to Develop a Medical Countermeasure for Thermal Burnshttps://practicaldermatology.com/news/20130829-novan_awarded_contract_by_barda_to_develop_a_medical_countermeasure_for_thermal_burns/2459472/
- FDA Approves Valchlor Gel for the Treatment of Stage IA and IB Mycosis Fungoides-Type CTCLhttps://practicaldermatology.com/news/20130826-fda_approves_valchlor_gel_for_the_treatment_of_stage_ia_and_ib_mycosis_fungoides-type_ctcl/2459475/
- Acne-Specific Dermatology Platform Site Goes Livehttps://practicaldermatology.com/news/20130801-acne-specific_dermatology_platform_site_goes_live/2459485/
- Viscot Releases Prep-Resistant Ink Markerhttps://practicaldermatology.com/news/20130611-viscot_releases_prep-resistant_ink_marker/2459516/AllSkin Plus+ with Prep Resistant Ink is the first prep-resistant ink marker that offers maximum visibility and prep resistance on all skin tones. Its VIXL brilliant blue ink provides enhanced visibility even after prep and other fluids and remains visible up to 10 times longer than traditional ink.